Effect of aluminum exposure on pteridine metabolism

Biological Trace Element Research

Volumn 106, Issue 2, 2005, Pages 153-164

  Baydar, T ^a   Engin, A B ^a   Aydin, A ^b   Sahin, G ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Aluminum; Atomic absorption spectrometer; Biopterin; Dihydropteridine reductase; High performance liquid chromatography; Neopterin; Pteridine

Indexed keywords

ALBUMIN; ALUMINUM; BIOPTERIN; CREATININE; DIHYDROPTERIDINE REDUCTASE; MAGNESIUM; METAL; METAL COMPLEX; NEOPTERIN; PTERIDINE;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OCCUPATIONAL EXPOSURE; SMOKING; STATISTICAL SIGNIFICANCE; URINE LEVEL;

ADULT; ALUMINUM; DIHYDROPTERIDINE REDUCTASE; ENVIRONMENTAL EXPOSURE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PTERIDINES; QUESTIONNAIRES; STATISTICS;

EID: 23844481397     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:106:2:153     Document Type: Article

References (29)

1. P. O. Ganrot, Metabolism and possible health effects of aluminium, Environ. Health Perspect. 65, 363-441 (1986).
2. P. Nayak, Aluminum: impacts and disease, Environ. Res. 89, 101-115 (2002).
3. A. Lione, Aluminum toxicology and the aluminum-containing medications, Pharm. Ther. 29, 255-285 (1985).
4. R. A. Yokel and P. J. McNamara, Aluminium toxicokinetics: an updated minireview, Pharmacol. Toxicol. 88, 159-167 (2001).
5. IPCS, Environmental Health Criteria 194: Aluminium, WHO, Geneva (1997).
6. C. D. Klaassen, Casarette & Doull's Toxicology, The Basic Science of Poisons, 6th ed., McGraw-Hill, New York (2001).
7. R. Duffin, P. S. Gilmour, R. P. Schins, et al., Aluminium lactate treatment of DQ12 quartz inhibits its ability to cause inflammation, chemokine expression, and nuclear factor-kappaB activation, Toxicol. Appl. Pharmacol. 176, 10-17 (2001).
8. M. S. Golub, P. T. Takeuchi, M. E. Gershwin, and S. H. Yoshida, Influence of dietary aluminum on cytokine production by mitogen-stimulated spleen cells from Swiss Webster mice, Immunopharmacol. Immunotoxicol. 15, 605-619 (1993).
9. C. Tzanno-Martins, L. S. Azevedo, N. Orii, et al., The role of experimental chronic renal failure and aluminium intoxication in cellular immune response, Nephrol. Dial. Transplant. 11, 474-480 (1996).
10. H. Wachter, D. Fuchs, A. Hausen, G. Reibnegger, and E. R. Werner, Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application, Adv. Clin. Chem. 27, 81-141 (1989).
11. H. Wachter, D. Fuchs, A. Hausen, et al., Neopterin Biochemistry: Methods of Clinical Application, de Gruyter, Berlin (1992).
12. C. Murr, L. C. Fuith, B. Widner, B. Wirleitner, G. Baier-Bitterlich, and D. Fuchs, Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res. 19, 1721-1728 (1999).
13. A. Niederwieser and H. C. Curtius, Tetrahydrobiopterin biosynthetic pathway and deficiency Enzyme 38, 302-311 (1987).
14. H. Shintaku, A. Niederwieser, W. Leimbacher, and H. C. Curtius, Tetrahydrobiopterin deficiency: assay for 6-pyruvoyl-tetrahydropterin synthase activity in erythrocytes, and detection of patients and heterozygous carries, Eur. J. Pediatr. 147, 15-19 (1988).
15. Z. Z. Altindag, G. Sahin, F. Inanici, and Z. Hascelik, Urinary neopterin excretion and dihydropteridine reductase activity in rheumatoid arthritis, Rheumatol. Int. 18, 107-111 (1998).
16. Z. Z. Altindag, G. Sahin, A. Isimer, A. Akpek, and Z. Hascelik, Dihydropteridine reductase activity and urinary neopterin levels in leukemias and lymphomas: is there any correlation between these two parameters? Leuk. Lymphoma 35, 367-374 (1999).
17. T. Baydar, A. Papp, A. Aydin, et al., Accumulation of aluminum in rat brain, Biol. Trace Element Res. 92, 231-244 (2003).
18. J. Harris, B. B. Bartelson, E. Barker, R. Balkissoon, K. Kreiss, and L. S. Newman, Serum neopterin in chronic beryllium disease, Am. J. Ind. Med. 32, 21-26 (1997).
19. Z. Z. Altindag, T. Baydar, A. Isimer, and G. Sahin, Neopterin as a new biomarker for the evaluation of occupational exposure to silica, Int. Arch. Occup. Environ. Health 76, 318-322 (2003).
20. W. Schobersberger, G. Hoffmann, P. Hobisch-Hagen, et al., Neopterin and 7,8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2, FEBS Lett. 397, 263-268 (1996).
21. I. Smith, D. W. Howells, and K. Hyland, Pteridines and mono-amines: relevance to neurological damage, Postgrad. Med. J. 62, 113-123 (1986).
22. R. J. Leeming and J. A. Blair, Dialysis dementia, aluminium, and tetrahydrobiopterin metabolism, Lancet 1(8115), 556 (1979).
23. P. Altmann, F. Al-Salihi, K. Butter, et al., Serum aluminium levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis, N. Engl. J. Med. 317, 80-84 (1987).
24. S. M. Sprague and J. G. Umans, Aluminum and dihydropteridine reductase in dialysis patients, N. Engl. J. Med. 317, 1604 (1987).
25. S. Milstien and S. Kaufman, Letter to the editor, N. Engl. J. Med. 317, 1605 (1987).
26. P. Altmann, U. Dhanesha, C. Hamon, J. Cunningham, J. Blair, and F. Marsh, Disturbance cerebral function by aluminium in haemodialysis patients without overt aluminium toxicity Lancet 2(8653), 7-12 (1989).
27. I. Smith and K. Hyland, Disturbance of cerebral function by aluminium in haemodialysis patients, Lancet 2(8661), 501-502 (1989).
28. K. I. Bolla, S. Milstien, G. Briefel, L. Wieler, and S. Kaufman, Dihydropteridine reductase activity: lack of association with serum aluminium levels and cognitive functioning in patients with end-stage renal disease, Neurology 41, 1806-1809 (1991).
29. K. A. Winship, Toxicity of aluminium: a historical review, Part 2. Toxicol. Rev. 12, 177-211 (1993).